<?xml version="1.0" encoding="UTF-8"?>
<svg height="631.719" width="533.08485996" xmlns="http://www.w3.org/2000/svg">
 <g style="fill:none;">
  <text svg_rhmargin="102.103" x="76.272,81.588,85.127,89.558,92.802,95.902,99.003,102.103" y="21.089000000000055" style="fill:#000000;font-family:AKYTAJ+URWPalladioL-Ital;font-size:7.97px;font-style:italic;font-weight:normal;">Cancers </text>
  <text x="104.096,108.081,112.066,116.051" y="21.089000000000055" svg_rhmargin="120.036" style="fill:#000000;font-family:DPYECX+URWPalladioL-Bold;font-size:7.97px;font-style:NORMAL;font-weight:BOLD;">2019</text>
  <text svg_rhmargin="122.029" x="120.036,122.029" y="21.089000000000055" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:7.97px;font-style:NORMAL;font-weight:normal;">, </text>
  <text x="124.021,128.006" y="21.089000000000055" svg_rhmargin="131.991" style="fill:#000000;font-family:AKYTAJ+URWPalladioL-Ital;font-size:7.97px;font-style:italic;font-weight:normal;">11</text>
  <text x="131.991,133.984,135.976,139.961,143.94600000000003,495.794,499.779,501.772,506.123,508.777,510.77,514.755" y="21.089000000000055" svg_rhmargin="518.74" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:7.97px;font-style:NORMAL;font-weight:normal;">, 47 2 of 27</text>
  <text x="97.795,105.391,108.57400000000001,110.8,116.668,120.348,125.025,129.165,133.841,139.524,142.706,145.147,147.432,153.339,157.195,161.335,164.518,167.769,169.995,174.135,178.811,183.146,188.477,194.159,200.125,203.376,205.612,208.794,214.477,217.318,220.989,226.954,230.205,232.441,235.693,241.023,246.911,250.767,253.95,259.632,262.883,265.109,270.538,275.215,280.897,285.573,289.43,294.312,297.495,300.336,305.666,311.348,313.575,320.497,328.093,334.615,338.755,340.99,346.673,351.554,357.071,361.747,363.973,369.372,374.049,378.726,384.408,386.644,392.511,396.182,401.513,407.479,413.366,417.701,422.378,428.34299999999996,430.579,435.46,441.143,447.10799999999995,449.334,452.517,457.194,461.333,464.516,469.193,475.15799999999996,477.384,480.225,485.90700000000004,488.143,492.478,495.319,498.161,503.843,506.684,511.019,515.901" y="55.95799999999997" svg_rhmargin="518.742" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">At present, ﬁrst- second- third- fourth- generation CARs have been produced and tested in clinical</text>
  <text x="76.535,79.848,83.862,86.819,91.9,94.857,99.165,101.706,106.218,112.447,118.361,123.229,126.196,132.344,136.358,140.666,143.97899999999998,146.946,152.596,157.464,163.378,168.246,172.26,177.341,180.653,183.61,189.159,195.07299999999998,198.04,205.245,213.151,219.939,224.248,227.215,231.727,237.275,243.189,247.498,250.455,254.764,258.077,261.044,266.592,269.976,272.943,278.024,280.981,285.29,289.802,295.452,301.194,304.16,309.241,315.156,318.468,321.425,327.045,332.593,338.802,343.345,345.886,348.974,355.102,359.41,364.278,370.487,373.454,376.838,382.386,386.40000000000003,389.368,392.68,397.761,401.592,407.242,412.11,415.423,418.39,424.009,426.966,432.881,439.09,442.047,447.961,453.611,456.152,459.241,463.752,469.301,475.215,481.129,485.997,490.509,493.821,498.689,504.898,507.855,513.474" y="69.46799999999996" svg_rhmargin="519.124" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">trials. The ﬁrst generation CARs consist of a scFv antibody, used for target binding, connected by</text>
  <text x="76.535,81.616,85.03,89.339,95.446,100.527,105.039,109.907,113.92099999999999,117.335,123.544,129.092,138.065,143.146,146.103,152.017,154.558,158.206,163.856,168.723,174.638,179.505,183.519,188.6,191.557,194.514,200.16400000000002,203.589,206.901,212.816,217.684,221.098,224.522,230.172,237.926,243.00699999999998,246.421,253.626,262.08,267.161,274.366,282.821,287.902,290.443,294.09,297.403,302.951,306.366,309.678,315.593,320.461,323.874,327.187,331.201,336.282,342.196,346.505,355.478,360.345,369.318,374.938,378.952,384.033,389.947,394.815,398.239,402.548,405.505,411.155,417.069,422.15,425.107,428.064,433.978,439.628,443.042,449.251,454.8,463.773,468.854,471.811,477.72499999999997,481.139,486.688,490.072,493.486,500.691,508.556" y="82.97699999999998" svg_rhmargin="513.637" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">a spacer domain, generally the IgG1 CH1CH2, to the transmembrane signaling domain of CD3</text>
  <text x="513.639" y="82.97699999999998" svg_rhmargin="518.741" style="fill:#000000;font-family:MGUWOX+EURM10;font-size:9.96px;font-style:NORMAL;font-weight:normal;">ζ</text>
  <text x="76.535,82.018,87.571,90.845,95.866,98.789,104.633,109.444,115.58,118.07,121.414,125.21,130.693,139.56,142.051,145.325,151.169,155.979,158.47,164.626,167.127,171.585,176.396,179.318,182.24,184.731,188.517,193.327,197.786,202.596,208.631,211.905,217.388,220.622,223.133,226.226,232.381,238.226,243.036,248.619,251.12,256.965,261.986,267.66,272.47,274.961,277.883,280.805,289.673,292.595,295.869,300.89,304.164,307.086,312.569,318.414,322.67199999999997,325.162,328.085,333.929,336.43,341.451,350.318,356.354,359.276,362.198,368.274,372.733,377.754,381.027,383.95,389.433,395.277,397.788,400.279,406.314,411.124,415.091,419.349,422.271,426.529,429.803,434.613,440.458,444.917,449.727,452.238,454.738,459.759,465.604,471.74,474.23,479.251,485.096,488.37,491.292,494.566,500.621,509.489,514.972" y="96.48699999999997" svg_rhmargin="518.939" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">obtained from the T cell receptor. They have limitations in ampliﬁcation, persistence, and antitumor</text>
  <text svg_rhmargin="110.506" x="76.535,81.403,84.604,90.751,95.263,100.344,104.856,110.506" y="109.99599999999998" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">efﬁcacy </text>
  <text svg_rhmargin="144.05" x="113.265,116.164,121.962,124.453,130.082,132.981,138.61,144.05" y="109.99599999999998" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">in vivo </text>
  <text x="146.808" y="109.99599999999998" svg_rhmargin="150.192" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">[</text>
  <text x="150.191" y="109.99599999999998" svg_rhmargin="155.172" style="fill:#0875b7;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">6</text>
  <text x="155.173" y="109.99599999999998" svg_rhmargin="160.254" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="160.254" y="109.99599999999998" svg_rhmargin="165.235" style="fill:#0875b7;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">8</text>
  <text x="165.235,168.619,171.16,175.051,181.281,187.195,192.063,194.816,199.125,203.992,208.504,214.053,219.967,226.17600000000002,228.94,234.59,239.457,245.371,250.239,254.253,259.334,262.647,265.604,271.152,277.066,279.82,287.025,294.931,301.719,306.028,308.791,313.872,320.081,326.29,331.158,337.367,340.12,344.632,350.181,354.489,357.802,360.759,369.732,375.86,378.817,383.898,387.211,392.759,396.773,402.423,405.187,414.16,419.708,422.665,427.533,432.045,438.172,441.129,445.997,450.30600000000004,453.059,456.443,460.752,466.879,471.391,477.305,480.07,485.151,489.46000000000004,492.213,499.418,507.283,512.364,517.445" y="109.99599999999998" svg_rhmargin="519.985" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">]. The second generation CARs added costimulatory molecules (such as CD28,</text>
  <text x="76.535,81.521,84.842,89.828,95.922,102.01599999999999,104.488,109.933,113.87200000000001,116.355,124.194,130.846,135.832,140.818,144.139,146.612,149.863,155.308,157.781,163.775,167.535,172.98,178.614,181.516,187.609,192.386,194.869,199.098,203.875,208.302,213.747,219.552,225.646,228.118,232.346,235.248,240.793,246.597,251.583,254.485,258.714,261.187,264.511,269.492,272.813,275.306,278.388,284.501,290.305,295.082,297.565,300.816,306.62,309.522,313.282,319.376,321.848,327.393,332.17,337.974,342.75,346.69,351.676,354.927,357.829,363.274,369.078,371.551,378.622,386.38,393.042,397.27099999999996,399.744,408.061,412.838,416.597,421.37399999999997,423.857,428.086,432.862,436.802,439.704,444.48,448.709,451.182,455.61,461.055,466.859,472.663,477.44,481.868,485.119,489.896,495.99,498.462,506.779,509.681,512.932" y="123.505" svg_rhmargin="518.736" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">4-1BB or OX40) to provide second signals [8]. The third generation CARs were series connected with</text>
  <text x="76.535,85.218,91.147,94.008,97.214,100.075,105.985,108.847,113.55699999999999,116.044,120.41,125.779,129.948,133.154,136.015,144.698,150.627,153.489,158.405,161.611,166.98,170.864,176.33100000000002,178.829,184.837,190.205,198.888,203.805,206.656,212.379,216.548,219.046" y="137.015" svg_rhmargin="222.32" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">multiple costimulatory domains [</text>
  <text x="222.318" y="137.015" svg_rhmargin="227.299" style="fill:#0875b7;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">9</text>
  <text x="227.3,230.574,233.032,236.12,239.434,242.64,245.127,250.85,255.767,259.936,262.434,267.871,272.581,277.291,283.014,285.502,289.868,295.237,300.96,306.909,310.793,319.475,324.185,330.193,332.681,335.887,341.61,346.526,349.732,352.229,355.435,361.158,365.868,368.356,372.525,377.235,381.601,386.97,392.693,398.70099999999996,401.188,406.105,411.828,417.83599999999996,420.323,423.529,429.252,432.113,435.82,441.828,444.316,449.783,454.493,460.216,464.926,468.81,473.727,476.933,479.794,485.163,490.886,493.383,500.355,508.005,514.574" y="137.015" svg_rhmargin="518.743" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">]. It has been conﬁrmed that the second and third generation CARs</text>
  <text x="76.535,81.047,86.595,92.723,95.68,101.88900000000001,104.927,107.884,116.857,122.965,126.806,132.354,138.096,142.964,146.001,150.869,154.07,160.218,164.73,169.811,174.322,179.972,183.011,185.968,191.88199999999998,194.921,199.229,204.778,213.75,218.618,221.656,224.969,231.097,240.07,245.618,249.632,253.941,256.989" y="150.524" svg_rhmargin="260.373" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">could improve efﬁcacy in some tumors [</text>
  <text x="260.37,265.351" y="150.524" svg_rhmargin="270.332" style="fill:#0875b7;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">10</text>
  <text x="270.332,273.716,276.257,280.992,287.221,293.135,298.003,301.051,310.024,315.105,318.062,323.976,327.015,331.323,334.28,340.489,345.35699999999997,348.395,353.263,356.464,359.848,364.715,369.227,372.54,376.84900000000005,379.887,384.399,389.48,395.607,399.916,404.783,410.992,414.031,419.65,425.29999999999995,428.349,435.554,443.459,450.247,453.286,459.515,462.554,467.065,471.933,474.89,477.847,482.156,485.194,488.151,494.065,498.577,501.534,507.662,513.871" y="150.524" svg_rhmargin="518.739" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">]. The main side effects caused by CAR T cells include</text>
  <text x="76.535,80.954,86.488,89.732,95.166,100.7,103.596,109.389,114.15599999999999,116.654,120.406,125.174,128.07,132.837,137.813,142.033,146.79999999999998,149.309,153.529,159.062,164.855,170.936,174.688,180.122,188.91,193.677,196.176,199.49,206.546,213.195,218.42,221.734,224.222,226.73,232.264,236.195,241.172,244.486,247.73,251.045,256.668,261.435,265.366,269.586,275.588,279.808,283.122,288.914,294.348,298.568,301.813,304.311,310.392,313.288,317.508,322.276,327.252,331.472,336.239,338.737,342.051,349.645,356.831,365.112,372.815,376.129,378.617,381.125,386.918,391.685,397.687,401.439,406.873,409.769,415.203,420.737,423.633,428.05199999999996,430.55,434.77,440.304,449.092,455.074,458.318,463.752,472.54,476.76000000000005,479.268,482.583,490.853,496.078,499.392,501.891,506.867,512.659" y="164.034" svg_rhmargin="518.74" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">cytokine release syndrome (CRS), graft-versus-host disease (GVHD), neurologic symptoms (NS) and</text>
  <text x="76.535,79.809,85.864,94.732,100.215,104.182,106.662,109.584,115.168,119.426,122.348,126.606,129.096,133.354,138.938,144.782,150.918,154.704,160.187,169.055,173.865,176.345,179.69,185.845,191.981,197.253,200.59699999999998,203.088,206.427,211.408,216.39,219.734,222.245,224.725,229.746,238.614,244.097,249.941,255.524,258.015,261.289,267.134,271.944,280.811,283.322,285.802,293.465,300.715,309.07,316.843,319.334,324.817,330.661,333.584,339.16700000000003,341.648,347.492,352.513,358.549,364.584,369.394,375.239,379.49699999999996,381.977,390.353,396.197,401.008,406.852,409.343,415.398,419.656,422.578,428.423,434.00600000000003,436.487,441.508,447.352,449.833,454.854,457.777,460.699,466.182,471.766,476.576,482.42,487.231,490.153,494.612,497.102,504.222,512.035" y="177.543" svg_rhmargin="518.743" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">tumor lysis syndrome (TLS) [11], among them, GVHD only happens when using an allogeneic CAR</text>
  <text x="76.226,82.455,85.504,93.979,96.936,100.249,106.163,111.711,117.839,121.152,124.2,130.307,134.138,139.006,144.747,147.704,153.253,159.38,163.689,166.738,172.967,176.015,180.527,185.395,188.352,191.309,194.357,198.189,203.056,207.568,212.435,218.543,221.855,227.404,231.418,234.466,240.675,245.543,248.5,253.367,256.68,259.637,265.186,271.1,273.641,278.406,284.635,290.549,295.417,298.466,301.849,307.398,313.525,317.539,320.852,326.76599999999996,329.815,335.465,340.332,346.247,351.114,355.128,360.209,363.522,366.479,372.027,377.941,380.99,388.195,396.101,402.889,407.19800000000004,410.246,413.63,416.943,421.81,425.824,434.797,439.664,445.873,448.922,455.151,461.939,469.845,477.05,484.428,487.476,493.705,496.754,501.266,506.133,509.09,512.047,516.356" y="191.05200000000002" svg_rhmargin="519.74" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">T without previous T cell receptor deletion. The fourth generation CARs (termed TRUCK T cells)</text>
  <text x="76.535,81.581,85.386,90.22,92.703,98.869,101.806,104.985,108.345,113.179,116.984,121.818,127.692,130.982,133.455,136.815,140.63,146.14,155.051,157.524,163.63,167.616,171.895,175.185,178.546,181.019,185.298,190.132,194.613,200.123,205.997,212.163,215.524,218.006,221.296,227.17,230.107,233.911,240.078,243.439,245.911,251.522,256.356,262.23,267.064,271.05,276.096,279.386,282.323,287.834,293.708,296.19,303.345,311.197,317.938,322.217,324.74,327.819,334.005,339.879,344.713,350.324,352.807,361.223,366.058,369.862,374.696,377.169,382.003,387.877,393.488,396.425,402.298,407.132,411.967,415.781,420.605,426.771,429.254,432.544,438.054,440.527,445.361,450.569,456.634,460.449,465.283,469.562,473.841,476.314,480.795,486.406,489.696,495.206,500.818,503.754,509.628,514.462" y="204.562" svg_rhmargin="518.741" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">are different from ﬁrst- second- third- generation CARs. They were engineered to express cytokines</text>
  <text x="76.207,79.498,85.438,90.379,94.283,97.505,100.381,104.769,110.728,113.604,118.545,122.449,125.325,130.82,133.32,136.651,142.689,145.98,150.922,155.863,159.154,161.664,164.886,170.638,175.58,178.80200000000002,181.302,185.69,191.086,197.045,199.921,205.95999999999998,208.47,213.935,218.669,221.169,227.129,231.319,236.053,242.09199999999998,244.602,247.824,253.22,255.72,259.446,264.18,269.675,275.634,278.51,283.451,286.673,291.407,293.917,297.139,302.881,307.61499999999995,310.125,315.067,320.819,324.04,326.916,330.138,336.098,344.824,350.22,354.124,356.624,359.5,368.227,376.953,382.913,388.665,394.061,396.937,402.333,407.828,410.704,415.092,417.602,426.328,429.204,433.592,437.318,442.714,447.448,453.2,458.784,461.66,465.386,470.782,476.534,485.26,489.994,495.746,498.96799999999996,501.468,504.759,509.74,514.722,518.013" y="218.07100000000003" svg_rhmargin="520.484" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">(particularly IL-12) that could be used to regulate the antitumor immunologic microenvironment [12].</text>
  <text x="76.535,82.573,87.307,91.498,94.374,100.412,105.146,109.336,111.807,114.298,117.173,120.395,122.876,125.752,129.942,132.433,137.928,142.661,148.413,153.147,157.051,161.992,164.868,167.744,173.239,175.73,181.195,185.929,188.805,191.681,196.415,201.998,206.732,212.771,215.251,218.473,224.225,229.166,232.388,234.879,241.886,249.575,256.17699999999996,258.667,264.72499999999997,267.206,271.594,276.328,279.204,282.08,286.27,288.76,297.003,299.879,303.1,308.85200000000003,311.343,317.095,319.971,325.465,331.217,335.951,339.855,342.336,348.374,353.77,357.96,362.694,366.884,369.375,374.317,380.068,386.10699999999997,388.597,391.473,396.869,402.621,408.116,412.85,416.754,419.234,425.174,429.908,433.812,438.002,440.878,445.068,448.29,453.024,458.776,463.164,467.89799999999997,470.388,473.287,479.085,481.576,487.205,490.104,495.733,501.173,503.659,508.047,512.988" y="231.58100000000002" svg_rhmargin="518.74" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">Besides, it is generally believed that CAR T cells with higher doses and longer persistence in vivo can</text>
  <text x="76.535,79.434,84.206,89.188,95.275,97.765,101.013,106.453,108.943,114.453,119.225,122.473,125.72,130.492,134.427,136.918,140.674,145.446,149.67,155.658,161.098,166.896,171.12,175.892,178.383,182.318,187.299,190.547,195.319,199.54299999999998,202.034,207.015,212.813,218.89999999999998,221.391,224.29,229.73,238.039,242.811,246.746,249.237,255.892,262.547,265.038,267.528,271.284,276.056,280.28,286.268,291.04,295.463,298.711,301.61,307.239,312.011,314.91,319.344" y="245.09000000000003" svg_rhmargin="321.835" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">lead to better response rates and lower RR, respectively.</text>
  <text x="97.795,104.887,112.629,117.63,122.631,125.122,132.213,139.995,146.67600000000002,149.158,155.289,157.78,162.221,167.012,169.923,172.833,177.074,179.555,185.376,190.378,196.029,200.82,203.311,207.552,213.373,218.835,227.177,232.998,235.479,240.48000000000002,242.971,247.212,250.472,255.474,261.005,263.916,268.707,271.197,276.199,282.02,285.281,288.192,291.452,297.484,306.316,311.777,315.728,318.209,323.0,326.151,332.202,336.643,341.645,346.086,351.647,354.138,357.048,362.869,365.35,371.362,376.363,379.624,382.535,387.326,393.147,396.408,400.649,403.14,411.482,414.392,417.653,423.47400000000005,425.955,429.726,434.517,438.958,444.99,448.941,452.712,457.503,463.324,466.58500000000004,469.076,475.187,477.678,482.119,486.91,489.821,492.732,495.212,500.213,504.654,510.686,513.947" y="258.59900000000005" svg_rhmargin="518.738" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">CD19 CAR T cells have shown a stable antitumor efﬁcacy in patients with recurrent B cell acute</text>
  <text x="76.535,79.492,85.142,94.115,100.222,106.136,111.685,117.304,120.261,125.342,129.651,132.964,135.921,140.433,143.451,146.408,151.275,157.403,163.053,167.921,176.893,179.851,184.932,187.96,191.344,197.552,200.936,208.842,215.051,221.26,224.644,227.185,230.202,237.407,243.616,249.825,252.36599999999999,255.394,260.475,266.389,272.598,275.616,281.53,287.078,292.993,296.376,304.831,310.379,316.588,322.238,327.888,330.845,336.76,339.585,343.894,346.921,349.879,355.529,364.501,370.609,376.523,382.071,391.044,396.125,399.143,402.527,410.972,419.426,425.635,429.019,432.047,435.004,440.918,443.937,447.768,452.635,457.147,462.015,467.929,471.24199999999996,474.27,479.92,484.787,489.868,493.882,498.19100000000003,501.209" y="272.10900000000004" svg_rhmargin="504.593" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">lymphoblastic leukemia (B-ALL), CLL, and non-Hodgkin’s lymphoma (NHL) in recent years [</text>
  <text x="504.597,509.578" y="272.10900000000004" svg_rhmargin="514.559" style="fill:#0875b7;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">13</text>
  <text x="514.559,517.943" y="272.10900000000004" svg_rhmargin="520.483" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">].</text>
  <text x="76.147,84.053,88.362,92.091,97.172,103.086,106.815,109.773,118.745,127.718,133.846,139.76,145.309,148.621,154.536,159.403,163.417,168.498,174.605,180.255,183.985,192.958,197.825,201.138,207.052,212.6,218.809,221.35,225.394,232.599,240.505,247.293,251.022,257.251,260.981,264.294,270.208,275.075,279.089,284.17,290.278,295.928,299.657,305.571,310.652,314.961,318.69,324.604,330.153,333.466,337.195,342.743,348.657,351.614,357.26399999999995,360.994,366.908,371.989,378.198,381.927,385.758,390.626,399.599,404.68,408.694,414.344,419.425,425.044,428.001,432.86899999999997,436.598,441.466,444.677,450.814,455.326,460.407,464.919,470.56899999999996,474.299,477.256,483.16999999999996,486.899,491.208,496.075,501.817,506.684,510.698,515.779" y="285.61800000000005" svg_rhmargin="518.736" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">As an immunotherapy method, CAR T therapy has not only had remarkable efﬁcacy in several</text>
  <text x="76.535,82.217,86.894,95.515,100.397,103.579,108.91,111.751,117.082,122.511,125.352,129.687,131.825,140.446,145.328,148.169,151.01,156.438,162.121,167.002,172.684,177.019,179.861,184.537,188.677,191.118,193.324,198.723,204.611,207.79399999999998,209.941,215.624,220.505,224.64499999999998,226.783,231.665,234.506,238.646,243.97699999999998,246.115,250.996,255.331,261.013,263.855,268.531,274.048,278.724,284.68899999999996,286.828,291.71,293.848,298.183,302.859,306.716,309.899,314.78,317.621,323.303,325.442,330.118,333.194,339.101,343.436,348.317,352.652,358.08,360.219,363.47,368.801,372.657,374.796,383.417,388.298,393.981,399.409,401.557,406.888,410.071,415.753,420.43,424.286,426.424,432.39,435.231,438.296,441.557,446.234,449.905,454.582,460.264,463.447,465.585,471.267,475.944,484.565,489.447,492.63,497.96,500.801,506.132,511.561,514.402" y="299.128" svg_rhmargin="518.737" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">hematologic malignancies, but has also achieved a certain efﬁcacy for many other different hematologic</text>
  <text x="76.535,81.506,87.293,93.36800000000001,95.844,100.059,105.488,108.381,111.275,117.35000000000001,119.835,128.615,133.586,136.479,139.373,144.901,150.687,155.659,161.445,165.86,168.753,173.516,177.732,180.207,183.101,188.888,191.363,195.778,198.671,201.564,207.351,210.244,214.659,219.63,222.523,225.009,228.25,232.178,235.071,240.042,242.936,247.151,249.637,252.113,256.328,262.324,266.738,272.525,275.011,279.982,284.19800000000004,286.674,292.202,295.095,297.988,303.417,308.915,311.809,316.78,320.996,324.237,329.666,338.445,343.417,345.892,349.203,356.789,362.864,372.27,375.581,378.067,380.552,386.339,391.102,397.097,400.845,406.274,411.772,414.666,419.637,423.853,427.094,432.523,441.302,446.274,448.749,452.06,460.322,466.397,469.708,472.194,474.67,480.456,485.885,491.672,494.983,499.198,507.978,512.949,515.842" y="312.637" svg_rhmargin="518.735" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">and solid malignancies in clinical trials, such as glioblastoma (GBM), neuroblastoma (NB), non-small</text>
  <text x="76.535,80.87,85.547,88.388,91.229,93.689,96.53,102.418,108.1,113.52799999999999,115.979,120.314,125.196,130.878,135.213,139.889,143.745,146.206,149.457,157.571,162.697,169.619,175.584,182.506,185.758,188.199,190.659,195.99,200.129,203.312,207.989,213.32,217.459,222.341,226.022,230.357,235.687,244.308,249.19,253.32999999999998,255.78,259.032,266.706,271.831,275.082,277.52299999999997,279.984,285.949,294.092,296.933,302.615,308.043,310.504,314.644,319.525,323.196,327.531,332.862,341.483,346.365,348.825,352.076,358.042,367.805,372.931,376.182,378.623,381.083,385.76,388.943,393.277,395.71799999999996,398.794,408.01,410.851,414.034,419.716,422.177,425.36,431.042,435.71799999999996,438.169,441.01,446.693,451.028,454.708,459.385,464.267,468.406,471.248,476.93,482.358,484.819,490.501,496.388,505.009,510.408,515.085" y="326.146" svg_rhmargin="518.942" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">cell lung cancer (NSCLC), osteosarcomas (OS), Ewing sarcoma (EWS), etc. With the increasing number</text>
  <text x="76.535,81.942,85.24,87.725,91.924,95.152,101.124,107.174,110.056,114.8,118.998,121.474,123.95,130.0,132.882,136.001,139.299,144.043,147.776,152.519,158.283,161.511,163.997,169.542,175.514,180.257,184.456,187.684,190.566,195.973,201.736,205.935,208.411,213.362,218.839,224.246,230.217,233.44500000000002,235.931,239.159,244.923,249.667,252.142,256.539,259.42,262.302,268.066,270.947,275.344,280.296,283.178,285.663,290.406,293.526,299.517,303.914,308.865,313.262,318.76800000000003,321.244,326.195,331.959,338.01,340.495,344.694,349.645,352.943,357.686,360.914,366.41999999999996,368.896,374.303,377.601,380.086,387.107,394.812,401.427,403.903,409.97400000000005,412.459,416.855,421.599,424.481,427.362,431.56100000000004,434.047,438.444,443.85,449.614,452.842,455.724,461.487,467.459,472.203,474.678,477.906,483.313,485.799,490.542,499.286,504.03,507.753,513.259,518.003" y="339.656" svg_rhmargin="520.479" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">of studies, different questions about the clinical efﬁcacy and safety of CAR T cells continue to emerge.</text>
  <text x="76.535,84.315,90.377,95.192,97.685,100.962,106.45,108.933,112.21,118.061,122.876,125.369,131.219,134.145,139.734,145.584,148.067,151.344,157.194,162.009,165.98,171.006,177.048,181.863,187.924,191.201,194.126,198.589,201.083,204.36,210.21,214.0,218.815,223.077,228.927,234.416,237.341,243.483,245.966,250.992,256.842,262.984,265.477,268.754,274.605,279.42,281.903,287.753,290.678,296.267,302.117,304.611,309.074,314.562,318.825,322.102,324.585,330.073,333.41999999999996,335.913,343.04,350.861,357.57599999999996,360.059,366.221,368.714,371.991,377.841,382.656,386.627,391.653,397.695,402.178,404.691,407.184,410.461,416.311,421.126,423.609,428.072,430.998,433.923,439.773,442.698,447.162,452.188,455.113,457.606,461.868,466.894,475.77,481.812,484.737,489.552,492.035,496.297,499.222,504.248,509.063,511.556,514.482" y="353.165" svg_rhmargin="518.744" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">Due to the high therapeutic threshold and the high cost of CAR T therapy, the clinical sample size is</text>
  <text x="76.535,80.717,83.932,86.802,89.672,92.542,95.038,97.908,100.778,109.487,112.357,115.573,120.297,126.323,128.819,133.001,138.386,140.881,144.165,149.097,152.263,154.729,157.224,161.948,166.13,172.058,176.782,181.161,184.032,188.963,191.833,194.703,200.187,202.682,205.553,211.293,213.788,217.003,222.744,227.468,229.963,235.891,240.823,244.038,246.908,251.632,257.373,260.588,264.77000000000004,267.265,275.491,278.361,281.576,287.31600000000003,289.812,293.994,299.379,302.249,305.119,311.14500000000004,313.641,322.35,327.281,330.152,333.022,338.505,344.246,349.177,354.918,359.297,362.167,366.891,371.073,373.539,376.646,384.852,390.237,398.463,403.187,408.759,413.484,416.65,419.116,421.611,425.793,431.178,434.048,436.918,442.944,445.44,454.149,459.08,461.95,464.821,470.304,476.045,480.976,486.716,491.096,493.966,498.69,502.872,505.367,510.299,514.017" y="366.675" svg_rhmargin="518.741" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">still limited so far, especially in the patients with solid malignancies. However, solid malignancies are</text>
  <text x="76.535,80.25,84.969,90.447,95.374,99.089,105.109,109.828,115.848,118.351,123.278,127.456,129.958,133.17,138.905,143.625,146.127,154.827,159.754,162.621,168.35500000000002,170.858,174.563,179.282,183.46,188.179,193.106,196.821,201.195,206.929,209.432,215.453,218.32,222.034,226.754,231.129,234.341,237.208,242.588,248.322,250.825,253.692,259.426,261.929,266.304,272.245,276.137,279.852,284.571,290.306,293.518,296.021,299.735,304.455,308.633,313.352,318.279,321.983,326.358,332.093,334.55600000000004,337.689,343.729,349.463,354.183,357.888,362.607,365.888,371.268,374.983,379.702,382.165,384.678,389.605,392.107,396.285,401.763,405.941,409.153,413.873,422.573,427.499,430.711,433.579,437.954,440.456,445.382,451.117,456.043,458.911,464.389,468.567,471.424,475.602,478.114,483.494,486.77500000000003,489.278,496.263,503.929,510.51099999999997,513.014" y="380.184" svg_rhmargin="519.054" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">regarded as the main research direction in current research. Therefore, a systematic analysis of CAR T</text>
  <text x="76.535,79.718,85.4,90.077,93.933,98.815,104.683,110.111,112.581,115.422,119.562,122.042,127.724,132.401,136.736,141.412,145.552,149.692,154.573,158.43,162.745,165.186,167.666,172.343,176.482,182.35,187.027,191.362,194.203,199.085,201.926,204.767,210.195,212.665,217.996,221.247,223.717,226.9,232.583,237.259,239.739,243.41,248.087,252.226,258.094,263.425,269.107,273.247,277.923,280.403,284.26,289.142,292.315,296.991,299.471,302.723,308.053,311.909,314.38,320.248,325.129,328.312,331.153,335.83,341.512,344.695,348.835,351.305,359.448,362.289,365.472,371.154,373.634,377.773,383.104,385.936,388.777,394.74199999999996,397.222,405.843,410.725,413.566,416.407,421.835,427.518,432.399,438.082,442.417,445.258,449.934,454.074,456.515,458.985,465.907,471.033,476.998,483.52,486.0,490.882,496.564,502.529,505.0,511.521,518.043" y="393.693" svg_rhmargin="520.484" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">therapy is necessary, especially of the response rate for patients with solid malignancies, CSER and RR.</text>
  <text x="76.226,82.431,88.322,91.267,95.559,98.049,102.341,105.641,111.744,117.929,123.557,126.036,131.097,134.043,142.981,147.273,149.762,153.062,158.589,161.069,167.152,170.978,176.505,182.224,185.169,191.354,196.20200000000003,198.682,203.743,206.233,210.525,216.153,220.444,223.744,228.592,237.53,242.591,245.891,248.836,253.33,255.821,259.637,264.485,270.204,273.15,277.998,286.44,288.92,294.446,297.817,300.307,307.483,315.358,322.119,324.61,330.815,333.294,336.594,342.485,347.334,351.332,356.393,362.476,368.104,370.594,373.894,379.785,383.601,389.127,395.231,400.859,406.75,409.24,418.178,423.026,426.326,431.387,434.757,439.818,445.709,450.77,453.716,459.344,463.636,466.581,470.873,473.404,475.883,480.175,486.278,491.876,497.504,501.33,506.856,512.96" y="407.203" svg_rhmargin="519.043" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">This study aims to provide a systematic review of CAR T therapy through meta-analysis, subgroup</text>
  <text x="76.535,81.516,87.315,92.296,95.195,100.734,104.958,107.857,112.081,114.572,119.554,125.352,131.439,133.93,142.727,147.499,150.746,155.728,159.045,162.801,167.573,173.112,176.868,181.64,185.865,190.089,192.988,198.427,204.225,206.716,211.698,217.496,222.477,225.376,230.915,235.14,238.039,242.263,244.75400000000002,247.244,252.684,255.822,259.139,263.911,267.847,270.746,276.544,282.08299999999997,284.574,289.55600000000004,292.046,295.802,300.574,303.891,308.664,312.419,317.192,322.99,327.413,332.185,334.676,337.993,343.433,347.368,349.859,352.758,356.006,360.22999999999996,362.721,366.038,372.046,375.293,381.301,385.057,389.829,392.32,397.301,403.288,409.276,412.175,415.074,419.498,424.479,427.727,430.626,436.065,441.863,444.354,449.336,455.134,461.221,463.712,467.468,472.24,476.464,481.236,486.217,489.973,494.396,500.195" y="420.712" svg_rhmargin="502.686" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">analysis and meta-regression analysis, offering a reference for its future application and research.</text>
  <text x="76.535,81.516,84.007,87.095,94.288,99.27,103.693,109.78,113.098,116.415" y="443.925" svg_rhmargin="120.838" style="fill:#000000;font-family:DPYECX+URWPalladioL-Bold;font-size:9.96px;font-style:NORMAL;font-weight:BOLD;">2. Results</text>
  <text x="76.535,81.516,84.007,88.988,91.479,94.567,101.212,105.088,108.963,112.839,117.262,120.958,125.013,129.995,132.485,139.13,143.005,146.881,152.42,155.19,158.507,162.383,164.873,169.297,174.836,179.818,182.308,190.059,195.598,200.021,202.791,205.561,208.878,213.85999999999999,216.35,223.543,227.419,231.294,235.169,239.045,242.92,250.671,254.547,260.086" y="467.138" svg_rhmargin="263.404" style="fill:#000000;font-family:AKYTAJ+URWPalladioL-Ital;font-size:9.96px;font-style:italic;font-weight:normal;">2.1. Research Results and Quality Assessment</text>
  <text x="97.795,103.878,109.653,114.406,116.886,119.774,122.661,125.896,130.649,134.569,139.53,142.765,148.748,152.489,157.24200000000002,159.713,163.92,168.673,173.635,177.375,181.781,187.556,190.037,196.0,199.741,205.159,209.565,214.318,218.525,222.732,225.203,233.479,238.44,242.647,245.128,248.015,253.791,258.196,261.084,267.067,273.13,277.883,283.94599999999997,286.426,289.314,295.089,297.57,302.532,305.002,310.995,317.624,320.968,326.177,335.564,343.28400000000005,345.764,351.798,357.215,365.491,367.972,374.034,376.922,381.883,387.4,391.32,396.281,405.043,407.514,410.818,416.335,419.223,424.74,430.723,434.464,439.217,441.698,446.659,451.62,454.925,457.406,460.491,466.554,472.07099999999997,474.542,478.283,483.036,488.642,491.53,496.283,504.558,507.446,513.221" y="486.625" svg_rhmargin="518.738" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">The literature search process was included in a PRISMA ﬂow diagram (Figure 1a). By reviewing</text>
  <text x="76.535,79.848,82.805,86.118,89.075,93.942,98.25099999999999,101.147,106.228,112.142,118.351,121.257,126.338,131.958,136.266,139.579,143.593,148.674,153.186,156.499,160.808,163.703,167.016,172.93,177.798,180.694,186.801,190.642,195.51,198.467,201.424,210.397,213.354,219.268,224.349,228.363,234.013,236.909,241.218,245.73,249.561,254.428,259.296,265.21,268.167,274.081,279.731,282.627,285.585,291.793,296.661,302.575,305.888,308.845,314.993,319.86,326.069,328.976,334.057,339.138,344.218,349.29900000000004,352.195,358.303,363.851,367.164,372.031,377.946,381.258,384.215,389.296,392.254,395.211,400.861,403.757,407.598,412.465,415.422,420.29,426.031,431.112,437.027,440.34,443.235,449.343,455.47,461.09,464.047,467.004,471.516,476.597,479.91,482.867,488.415,494.329,498.63800000000003,501.534,506.615,512.529" y="500.134" svg_rhmargin="518.738" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">titles and abstracts the preliminary screening identiﬁed 1589 potentially relevant publications and</text>
  <text x="76.535,81.616,86.697,91.778,95.416,99.928,102.885,105.842,111.756,114.713,119.225,124.306,127.26299999999999,130.901,134.742,139.61,145.717,151.265,155.279,158.592,162.901,165.442,171.975,179.881,183.265,186.578,191.445,195.459,199.097,202.928,207.796,216.769,222.317,228.058,231.015,236.93,242.58,246.228,252.437,258.564,264.672,267.629,270.586,275.098,280.178,283.491,288.359,292.667,295.20799999999997,299.13,304.211,309.292,314.373,319.454,323.092,329.199,334.748,338.06,342.928,348.842,352.155,355.112,360.193,363.15,366.788,370.629,375.497,378.454,383.321,389.063,394.144,400.058,403.371,407.009,413.116,419.243,424.863,427.82,430.777,435.289,440.37,443.683,446.64,452.188,458.102,462.411,466.049,471.13,477.044,483.253,486.891,491.403,494.36,497.317,503.231,506.188,510.7,515.781" y="513.644" svg_rhmargin="518.738" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">467 clinical reports. After removing duplicates, 1853 potential relevant publications and clinical</text>
  <text x="76.535,80.366,85.234,91.341,96.889,100.903,104.216,108.52499999999999,112.203,120.678,125.546,129.387,134.255,137.923,144.03,147.871,152.739,155.696,158.653,167.626,170.583,176.497,181.578,185.592,188.549,191.506,197.156,200.825,203.782,209.696,214.208,217.165,223.292,229.501,234.369,240.578,243.119,247.091,250.049,255.963,260.475,263.432,269.559,275.768,278.725,284.639,290.289,293.968,299.049,304.13,309.211,312.889,318.804,324.352,330.266,333.65,337.481,342.349,346.657,351.525,356.606,360.447,364.959,370.873,374.541,379.622,383.636,386.949,389.906,394.418,397.375,402.243,406.551,409.092,413.065,418.146,423.227,428.308,431.986,437.535,440.848,446.762,451.629,455.64300000000003,459.322,462.635,468.183,474.29,477.247,481.759,485.438,490.519,494.533,497.845,500.802,505.314,508.271,513.139,517.448" y="527.153" svg_rhmargin="519.988" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">reports were preliminarily included, including 716 non-research articles, 655 other topic articles,</text>
  <text x="76.535,81.616,86.697,91.778,95.599,101.726,107.64,112.152,117.701,126.674,132.781,135.738,140.605,143.918,148.786,154.995,158.816,162.647,167.514,173.621,179.17,183.184,186.496,190.805,193.346,197.502,202.583,208.497,214.70600000000002,218.527,223.607,228.688,232.509,238.423,243.972,247.285,251.105,254.489,260.617,263.574,266.531,269.915,273.228,278.095,283.339,286.652,290.473,295.553,299.567,302.88,305.837,310.349,313.306,318.174,322.482,325.023,332.106,338.335,344.249,349.117,355.031,358.852,367.327,372.195,376.015,379.399,385.526,389.54,392.853,398.767,403.635,407.649,411.47,415.778,420.29,424.131,428.999,433.866,439.781,444.648,450.857,454.678,457.991,463.905,468.77299999999997,472.593,476.424,481.292,490.265,495.346,498.303,504.217,507.174,513.088" y="540.663" svg_rhmargin="518.738" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">381 uncompleted reports, and 24 not full-text articles. Then we further screened the remaining</text>
  <text x="76.535,81.417,86.299,88.251,91.502,97.39,100.231,103.072,106.323,109.506,114.182,119.22,122.40299999999999,124.356,129.238,133.094,136.277,139.118,143.453,146.294,150.971,155.11,157.55100000000002,159.611,164.493,170.175,176.14000000000001,178.093,182.975,187.857,189.809,194.691,198.548,201.73,204.572,208.906,211.748,216.424,220.564,222.507,230.649,233.491,236.673,242.355,244.308,247.15,252.832,256.971,262.859,265.934,271.841,276.176,279.017,283.694,289.376,292.55899999999997,294.512,298.192,302.869,307.009,312.896,315.737,318.92,320.873,326.838,331.72,334.902,339.784,341.737,349.879,354.556,358.227,362.90299999999996,364.856,369.533,374.571,378.906,381.747,387.634,393.6,398.276,404.242,406.683,409.592,415.021,417.862,423.544,428.426,431.267,434.108,438.433,440.87399999999997,442.934,447.816,452.698,454.65,458.79,461.972,467.86,473.825,476.666,481.343,485.483,487.435" y="554.172" svg_rhmargin="490.686" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">77 full-text articles, and 25 articles with insufﬁcient result data were excluded. Finally, 52 studies [</text>
  <text x="490.682,495.663" y="554.172" svg_rhmargin="500.644" style="fill:#0875b7;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">14</text>
  <text x="500.645" y="554.172" svg_rhmargin="505.527" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="505.526,510.507" y="554.172" svg_rhmargin="515.488" style="fill:#0875b7;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">65</text>
  <text x="515.489" y="554.172" svg_rhmargin="518.74" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">]</text>
  <text x="76.117,84.592,89.673,93.982,97.66,100.617,106.531,111.043,114.0,120.128,126.337,131.204,137.413,141.082,144.039,149.95299999999997,153.632,159.18,165.308,169.322,172.99,176.831,181.699,186.007,190.875,195.956,199.787,204.299,210.213,212.754,216.727,219.684,225.598,230.11,233.067,239.194,245.403,248.36,254.275,259.925,263.593,269.741,273.125,276.438,282.088,285.471,291.02,296.934,301.802,305.48,311.689,317.603,323.253,326.21,329.167,333.476,339.39,343.059,347.367,350.68,356.808,363.017,365.974,370.841,375.15000000000003,378.828" y="567.681" svg_rhmargin="382.212" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">was included in our research, including ﬁfty-one English studies [</text>
  <text x="382.212,387.193" y="567.681" svg_rhmargin="392.174" style="fill:#0875b7;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">14</text>
  <text x="392.175" y="567.681" svg_rhmargin="397.256" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="397.256,402.237" y="567.681" svg_rhmargin="407.218" style="fill:#0875b7;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">40</text>
  <text x="407.218" y="567.681" svg_rhmargin="409.758" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">,</text>
  <text x="409.759,414.74" y="567.681" svg_rhmargin="419.721" style="fill:#0875b7;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">42</text>
  <text x="419.722" y="567.681" svg_rhmargin="424.803" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="424.803,429.784" y="567.681" svg_rhmargin="434.765" style="fill:#0875b7;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">65</text>
  <text x="434.765,438.149,441.828,446.908,452.823,459.032,462.7,468.248,474.163,479.031,482.709,489.913,495.828,498.785,504.699,509.566,513.875" y="567.681" svg_rhmargin="518.743" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">] and one Chinese</text>
  <text x="76.535,80.759,84.007,90.014,96.102,101.641,104.131,107.449,112.43,117.412,120.729" y="581.191" svg_rhmargin="123.22" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">study [41].</text>
  <text x="97.795,105.701,110.213,114.725,120.273,124.104,130.313,133.27,139.184,144.834,147.771,151.084,156.632,159.569,162.882,168.796,173.664,176.59,184.577,192.483,200.389,208.254,216.16,221.495,224.879,229.95999999999998,232.897,239.024,243.333,248.201,252.215,255.151,260.801,266.929,269.886,276.095,280.962,283.919,286.877,292.791,297.658,301.967,304.508,307.546,310.859,316.773,321.641,324.577,328.408,333.276,337.584,343.712,346.669,349.98199999999997,352.918,358.467,361.851,364.777,370.468,376.596,381.676,384.634,387.591,390.903,396.553,399.49,404.358,410.099,415.18,418.137,424.265,429.346,432.658,435.616,441.164,447.078,450.015,453.399,458.947,462.961,465.888,470.969,476.05,478.986,481.943,487.858,492.37,495.327,501.454,507.663,512.531" y="594.7" svg_rhmargin="518.74" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">According to the QUADAS-2 user guidelines, the result of quality evaluation for 52 included</text>
  <text x="76.535,80.675,83.858,89.745,95.71,98.551,103.228,107.368,109.721,117.863,122.745,126.885,129.238,133.377,139.059,144.39,152.533,158.21499999999997,160.568,163.409,169.09099999999998,171.435,176.512,181.393,186.792,189.634,194.30999999999997,196.653,201.535,203.976,207.022,214.618,220.3,226.26500000000001,228.619,231.802,237.484,242.16,244.513,250.381,254.052,259.383,265.251,270.582,274.438,277.621,280.462,285.793,291.475,293.828,299.159,302.40999999999997,304.763,308.903,312.086,317.973,323.938,326.779,331.456,335.596,337.949,346.091,348.932,352.115,357.797,360.15,362.992,368.322,375.547,377.988,380.37,386.053,388.894,394.322,400.004,402.348,407.678,411.534,413.888,419.775,425.458,429.792,432.634,437.31,442.192,446.048,448.401,452.258,455.099,459.239,464.667,467.02,472.351,475.602,477.955,483.354,486.195,491.077,495.217,497.57,505.712,510.389,514.06" y="608.21" svg_rhmargin="518.737" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">studies was shown in Table 1. And the proportion of studies with low, high or unclear risk of bias were</text>
  <text x="76.535,80.759,86.557,91.997,100.306,106.104,108.595,111.494,117.292,119.783,125.322,128.221,133.76,139.768,143.524,148.296,150.786,155.768,161.277,163.768,166.856,172.963,178.761,183.533,186.024,191.005,196.544,200.3,205.072,209.845,218.641,223.414,229.212,232.45999999999998,234.95,238.268,243.707,247.642,250.133,254.357,259.129,262.029,266.801,271.224,274.472,277.371,282.811,288.609,291.099,296.539,299.85699999999997,302.347,306.571,309.819,315.827,321.914,324.813,329.585,333.80899999999997,336.3,341.809,346.581,349.829,358.138,362.91,367.682,373.48,375.971,379.219,387.528,392.968,395.458,400.439,406.447,409.694,415.493,420.932,424.867,429.091,431.582,439.891,444.872,449.096,451.587,457.385,460.284,465.824,471.622" y="621.719" svg_rhmargin="474.113" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">shown in Figure 1b. The agreement for selection of studies between two authors was high.</text>
 </g>
</svg>
